Learn about dermatology coverage in health insurance plans. Explore critical illness insurance, top medical insurance ...
PECONDLE® (picankibart injection) has received approval from China's National Medical Products Administration (NMPA) for the treatment of ...
Innovent Biologics ( ($HK:1801) ) has provided an announcement. Innovent Biologics has announced that its new drug, PECONDLE® (picankibart ...
New long‑term clinical data show that TREMFYA® (guselkumab), an IL‑23 inhibitor, is the first treatment of its kind to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback